E. S. Andreyanova
Papers
1
Total Citations
3
H-Index
1
About
E. S. Andreyanova is a researcher focused on antimicrobial drug discovery, with a particular emphasis on developing innovative screening methodologies to combat the growing threat of antibiotic resistance. Her key research areas include high-throughput screening technologies, protein biosynthesis inhibition, and the mechanistic elucidation of antimicrobial compounds. Andreyanova’s most notable contribution is the development of a high-throughput screening platform for identifying new inhibitors of protein biosynthesis, detailed in her 2016 paper, which has garnered 3 citations. This work addresses the critical need for efficient methods that can simultaneously test thousands of compounds while uncovering their mechanisms of action—a dual challenge that has long hindered antibiotic discovery. By integrating mechanistic studies into large-scale screening, her platform streamlines the path from hit identification to understanding antimicrobial activity, offering a practical tool for both basic research and clinical applications. Andreyanova’s research bridges fundamental microbiology and translational medicine, providing a foundation for future antibiotic development. Her work is particularly relevant for students and researchers interested in assay design, drug screening, and the molecular mechanisms of bacterial protein synthesis.
Research Focus
Key Achievements
Top Papers
- 1